('and', 28)('-', 9)('of', 8)('the', 7)('development', 6)('for', 5)('Research', 4)('Leidos', 4)('support', 4)('is', 4)('to', 3)('activities', 3)('Biomedical', 3)('FNLCR', 3)('National', 3)('Technology', 3)('(DSITP)', 3)('Program', 3)('Data', 3)('MD', 3)('Science', 3)('as', 3)('Information', 3)('a', 3)('NCI', 3)('operations', 2)('(', 2)('Director', 2)('T', 2)('through', 2)('research', 2)('scientific', 2)('cancer', 2)('633671', 2)('approximately', 2)('clinical', 2)('Center', 2)('Inc.', 2)('Cancer', 2)('AT&amp', 2)('FFRDC', 2)('an', 2)('in', 2)(')', 2)('1', 2)('VA', 2)('Institute', 2)('(NCI)', 2)('bioinformatics', 2)('The', 2)('programs', 2)('analysis', 2)('breadth', 1)('webpage', 1)('mission:', 1)("FNLCR's", 1)('facilities', 1)('manages', 1)('including', 1)('wholly', 1)('its', 1)('Sodexo', 1)('Corporation', 1)('investigator-', 1)('Arlington', 1)('processes.', 1)('application', 1)('LBRI', 1)('R&amp', 1)('only', 1)('Federally', 1)('biomedical', 1)('under', 1)('has', 1)('image', 1)('emailed', 1)('provides', 1)('nanoinformatics', 1)('Funded', 1)('2', 1)('nanotechnology', 1)('unique', 1)('OpenText', 1)('advanced', 1)('resource', 1)('like', 1)('Computing', 1)('AIDS.', 1)('proteins', 1)('NIAID.', 1)('(ABCC)', 1)('Consultants', 1)('PROGRAM', 1)('Advanced', 1)('hypothesis-driven', 1)('|', 1)('therapeutic', 1)('mathematical', 1)('status', 1)('Management', 1)('financial', 1)('For', 1)('our', 1)('national', 1)('M.', 1)('operates', 1)('www.leidosbiomed.com.', 1)('laboratory', 1)('provided', 1)('Good', 1)('genetics', 1)('Administrative', 1)('Telephonics', 1)('Practice', 1)('please', 1)('current', 1)('web', 1)('safety', 1)('receiving', 1)('Description:', 1)('(FNLCR).', 1)('discovery', 1)('core', 1)('Infectious', 1)('infrastructure', 1)('jobs', 1)('business', 1)('(NCI).', 1)('WASHINGTON', 1)('(FFRDC)', 1)('diagnostic', 1)('focused', 1)('imaging', 1)('others', 1)('modeling', 1)('manufacturing', 1)('(LBRI)', 1)('by', 1)('$', 1)('on', 1)('900', 1)('annual', 1)('{emailaddress}', 1)('drug', 1)('simulation', 1)('products', 1)('Laboratory', 1)('efforts', 1)('NCI-', 1)('this', 1)('(NIAID)-sponsored', 1)('proteomics', 1)('into', 1)('owned', 1)('visualization', 1)('spans', 1)('AIDS', 1)('genomics', 1)('management', 1)('*', 1)('visit', 1)('start', 1)('maintenance', 1)('which', 1)('more', 1)('initiated', 1)('about', 1)('Hagerstown', 1)('DC', 1)('delivery', 1)('subsidiary', 1)('with', 1)('to:', 1)('operating', 1)('these', 1)('database', 1)('will', 1)('budget', 1)('following', 1)('Gaithersburg', 1)('employees', 1)('accelerate', 1)('dedicated', 1)('provides:', 1)('spectrum', 1)('research.', 1)('Clinical', 1)('expertise', 1)('at', 1)('You', 1)('technology', 1)('D', 1)('Development', 1)('information', 1)('Diseases', 1)('procurement', 1)('trials', 1)('responsible', 1)('sciences', 1)('conditions', 1)('biopharmaceutical', 1)('animal', 1)('Through', 1)('Manufacturing', 1)('projects', 1)('Oakton', 1)('Frederick', 1)('450', 1)('state-of-the-art', 1)('sponsored', 1)('proteomic', 1)('DESCRIPTION', 1)('effective', 1)('Allergy', 1)('well', 1)('It', 1)('Jobs.com', 1)('preventive', 1)('Columbia', 1)    633671 - Director, Data Science and Information Technology Program (DSITP) (NCI) - Leidos | Jobs.com
        Description:
        PROGRAM DESCRIPTION
        Leidos Biomedical Research, Inc. (LBRI), a wholly owned subsidiary of Leidos, operates the Frederick National Laboratory for Cancer Research (FNLCR). FNLCR is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI). It is the only FFRDC dedicated to biomedical research. Through its status as an FFRDC, FNLCR provides NCI and others with a unique national resource to accelerate the development and delivery of effective preventive, diagnostic, and therapeutic products for cancer and AIDS.
        The breadth of FNLCR's activities spans the research and development spectrum, including investigator- initiated, hypothesis-driven research into cancer and AIDS; advanced technology programs focused on genetics and genomics, proteins and proteomics, imaging, nanotechnology, bioinformatics, and laboratory animal sciences; clinical operations in support of NCI- and National Institute of Allergy and Infectious Diseases (NIAID)-sponsored clinical trials, as well as NCI drug discovery and development efforts; and management and operations of biopharmaceutical development and manufacturing programs under current Good Manufacturing Practice conditions for NCI and NIAID. Administrative, procurement, financial, safety, and facilities support is provided to these R&amp;D activities through state-of-the-art business processes. LBRI has approximately 1,900 employees and manages an annual operating budget of approximately $450M.
        For more information about Leidos Biomedical Research Inc., please visit our webpage at www.leidosbiomed.com.
        The Data Science and Information Technology Program (DSITP) is responsible for the following activities in support of the FNLCR mission:
        * Advanced Biomedical Computing Center (ABCC), which provides: (1) bioinformatics, mathematical simulation and modeling, image analysis and visualization, nanoinformatics, and proteomic analysis expertise and (2) core infrastructure support for scientific projects through database maintenance and development and scientific web application development
             Sodexo, WASHINGTON - DC
             OpenText, Gaithersburg - MD
             AT&amp;T, Arlington - VA
             Telephonics Corporation, Columbia - MD
             Clinical Management Consultants, Hagerstown - MD
             AT&amp;T, Oakton - VA
          633671 - Director, Data Science and Information Technology Program (DSITP) (NCI)
        You will start receiving jobs like this emailed to: {emailaddress}